genedrive plc (LON:GDR – Get Free Report)’s share price shot up 4.3% during mid-day trading on Wednesday . The company traded as high as GBX 2.40 ($0.03) and last traded at GBX 2.40 ($0.03). 1,421,360 shares were traded during trading, a decline of 90% from the average session volume of 14,291,111 shares. The stock had previously closed at GBX 2.30 ($0.03).
genedrive Trading Down 1.4 %
The company has a market cap of £12.85 million, a PE ratio of -60.00 and a beta of -0.04. The stock’s 50 day moving average is GBX 2.26 and its 200-day moving average is GBX 2.74. The company has a quick ratio of 5.52, a current ratio of 1.63 and a debt-to-equity ratio of 8.57.
Insider Activity at genedrive
In other genedrive news, insider Ian David Gilham purchased 1,000,000 shares of the firm’s stock in a transaction that occurred on Wednesday, August 14th. The shares were bought at an average price of GBX 3 ($0.04) per share, with a total value of £30,000 ($38,905.46). 14.75% of the stock is owned by insiders.
genedrive Company Profile
genedrive plc, a molecular diagnostics company, engages in developing and commercializing point of need diagnostics platform for infectious diseases, genotyping, pathogen detection, and other indications. The company provides Genedrive system, a rapid thermocycler and signal detection system and semi- automated system used forqualitative in vitro molecular diagnostic tests; and Genedrive CYP2C19 ID Kit, a point-of-care test for rapid CYP2C19 genotyping in time-critical emergency care settings.
Recommended Stories
- Five stocks we like better than genedrive
- Insider Trading – What You Need to Know
- Microsoft Can Hit New All-Time Highs This Year – Here’s Why
- Best Stocks Under $10.00
- Zillow Stock’s Bull Case: Why This Recent Sell-Off Could Be a Buy
- Bank Stocks – Best Bank Stocks to Invest In
- IonQ’s Quantum Surge: Ride the Wave or Cash Out?
Receive News & Ratings for genedrive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for genedrive and related companies with MarketBeat.com's FREE daily email newsletter.